Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

XBiotech Inc (XBIT) NPV

Sell:$12.52 Buy:$12.53 Change: $0.59 (4.50%)
NASDAQ:0.73%
Market closed |  Prices as at close on 15 November 2019 | Switch to live prices |
Sell:$12.52
Buy:$12.53
Change: $0.59 (4.50%)
Market closed |  Prices as at close on 15 November 2019 | Switch to live prices |
Sell:$12.52
Buy:$12.53
Change: $0.59 (4.50%)
Market closed |  Prices as at close on 15 November 2019 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

XBiotech Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing True Human monoclonal antibodies for treating a range of different diseases. It focuses on its lead product candidate, Xilonix (MABp1), which is derived from a natural human immune response. The Company has also developed a True Human monoclonal antibody discovery platform and manufacturing system. Xilonix is a therapeutic antibody, which specifically neutralizes interleukin-1 alpha (IL-1a). Its pipeline includes various human antibodies for treating diseases, such as cancer, vascular disease, inflammatory skin disease and diabetes. The Company has completed a Phase III study in Europe for the treatment of symptomatic colorectal cancer. It also investigated its lead product candidate in clinical trials for other inflammatory conditions, including vascular disease, type II diabetes, acne, psoriasis, pyoderma gangrenosum (PG) and hidradenitis suppurativa (HS).

Contact details

Address:
Building 4, 8201 E Riverside Dr Ste 100
AUSTIN
78744-1602
United States
Telephone:
+1 (512) 3862930

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
XBIT
ISIN:
CA98400H1029
Market cap:
$470.44 million
Shares in issue:
41.07 million
Sector:
Biotechnology
Exchange:
NASDAQ
Country:
Canada
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • John Simard
    Chairman of the Board, President, Chief Executive Officer, Founder
  • Sushma Shivaswamy
    Chief Scientific Officer
  • Queena Han
    Vice President - Finance, Director of Human Resources, Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.